| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963856 | Vaccine | 2015 | 8 Pages |
Abstract
An MF59-adjuvanted influenza vaccine containing 3.75 μg of A/H1N1 antigen was well tolerated and sufficiently immunogenic to meet all the European licensure criteria after a single dose in healthy children 3-17 years old.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Markus Knuf, Geert Leroux-Roels, Hans. C. Rümke, Katia Abarca, Luis Rivera, Maria Lattanzi, Paola Pedotti, Ashwani Arora, Dorothee Kieninger-Baum, Giovanni Della Cioppa,